Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,272 total articles
Maple Leaf Foods has seen a valuation reset as investors reward improving margins and a clearer strategic focus on branded protein. Although recent line-item financials were not available in the materials I reviewed, the company's operational momentum and several near-term catalysts support a mid-term long trade. Entry at $17.50, target $21.00, sto…
Micron is benefitting from a multi-year AI-driven surge in high-bandwidth memory and SSD demand. The company posts strong profitability metrics, $10.3B in free cash flow and a conservative balance sheet, yet trades at a reasonable multiple versus its growth run-rate. This trade plan buys MU at $420.70 with a $360 stop and a $520 target over a 180-t…
Eastman Chemical (EMN) traded higher earlier this year, but a pullback has rehypothecated the risk/reward in favor of buyers. With a market cap near $8.5B, P/E around 18x, EV/EBITDA ~8.7x, and a 4.5% dividend yield, the stock is cheap relative to its cash flow profile and differentiated specialty portfolio. This trade idea outlines a practical entr…
Nano Labs (NA) trades at a sub-$75M market cap after a strategic pivot into cryptocurrency reserves and a series of product and ecosystem moves. The combination of a very low price-to-book (0.66), a single-digit P/E (3.85), recent insider buying and technical signs of bullish momentum argue for a long trade with a 3x upside over the next 180 tradin…
Strattec (STRT) is executing an operational transformation that is translating into revenue growth, margin expansion and unusually high free cash flow. With a conservative balance sheet, attractive valuation and visible catalysts, the risk/reward favors a long position over the next 180 trading days. Entry $82.29, stop $72.00, target $105.00.
Centene (CNC) is trading at valuations that understate its cash-generation and exposure to Medicare rate upside. Recent CMS guidance and a beat on revenue give a path for margin betterment; pair that with a low EV/EBITDA and strong free cash flow and you have a high-conviction swing trade idea with defined risk.
<p>Perimeter Solutions (PRM) is a play on a stronger-than-normal wildfire season, improving underlying margins, and incremental upside from the recently closed MMT acquisition. The stock trades at $25.48 with positive technical momentum and a healthy free cash flow base; I’m initiating a long trade for the summer, looking for a re-rate toward a $33…
We like InfuSystem (INFU) as a long trade into 2026. The company pairs recurring rental and service revenue from infusion pumps and oncology support with improving profitability: free cash flow of $15.7M and an EPS base near $0.33 provide a credible path to revenue and margin expansion. At a market cap around $190M and an EV of $206M, the risk/rewa…
Doubleview Gold (DBLVF) is trading above its short- and medium-term moving averages with rising volume and compressed short interest. For traders willing to accept OTC-level risk and potential dilution, a disciplined long with a mid-term horizon captures a plausible M&A or news-driven re-rating.
Opera (OPRA) combines a high-single-digit revenue growth profile tied to advertising/search monetization with a 5.29% dividend yield and a cheap valuation (P/E ~12, PB ~1.3). Technicals show constructive momentum and short interest has been drifting lower. This is a pragmatic long trade for investors willing to hold through near-term volatility: en…
Sezzle appears to have completed a multi-month consolidation. With a cleaner operations narrative, improving merchant adoption and favorable seasonality ahead, the stock looks positioned for a re-rating. This is a mid-term swing trade with a defined entry at $1.20, a stop at $0.90 and a primary target at $2.40.
Eli Lilly's Foundayo approval is a structural positive for its obesity/weight-loss franchise, but near-term headline risk and pricing pressure in markets like India are already showing. I lay out a long trade that assumes disciplined launch execution and controlled margin impact, with a clear entry at $940.06, a stop at $880.00 and a target of $1,1…
Sabesp, São Paulo's dominant water utility, is at the center of renewed privatization chatter. If the privatization process proceeds with credible regulatory protections, the stock offers a path to a re-rating as private capital drives efficiency and clearer capex allocation. This is a conditional long idea with defined entry, stop and target level…
Teladoc is trading near the low end of its 52-week range at roughly $5.11 with a market cap around $909M, positive free cash flow of $166.9M and attractive valuation multiples (P/S 0.36, EV/EBITDA 5.65). Fundamentals look less dire than headlines suggest — this is a tactical long idea for a mid-term rebound while risks from competition, policy, and…
Tesla is volatile but not broken. With a $1.31T market cap, stretched multiples, and a short-term delivery miss, the stock has retraced into an area of asymmetric reward: downside capped by a strong balance sheet and upside tied to robotaxi economics, energy growth, and improving exports. We upgrade to Buy with a clear entry, stop and $460 target o…
Western Midstream (WES) pays a roughly 9% yield, reported a $0.91 quarterly distribution ($3.64 annualized) and generates meaningful free cash flow. The partnership trades near $41 and offers a defined risk/reward for a midterm (45 trading days) trade: collect yield while targeting capital appreciation toward $47, with a protective stop under $36.
Qualys shares have been pushed lower recently as chatter around a potential cybersecurity disruptor weighs on sentiment. The business remains subscription-driven with durable enterprise demand for cloud-native security; the pullback offers a measured swing-entry with defined risk and an asymmetric upside if fundamentals hold. This trade idea lays o…
Vistance Networks (VISN) looks like a more focused, less levered company after its $10B divestiture. The market cap sits at roughly $4.28B, the stock trades at ~ $19 and a low P/E of 3.2, technicals show bullish momentum, and institutional buying plus a planned special distribution support upside. This trade idea lays out an entry at $19.09, a $26 …
Hapag‑Lloyd's move to win the contested ZIM bid (priced at $35) has been met with skepticism. The market is understating two things: the strategic value Hapag‑Lloyd would capture and the technical squeeze dynamics in HLAGF shares. Given the stock's OTC liquidity profile, elevated short interest and current technical support, we upgrade to Buy with …
Arthur J. Gallagher & Co. (AJG) just traded back toward the low end of its 52-week range after a pullback. The business generates $1.785B in free cash flow, carries modest leverage and still yields a small dividend. For patient, risk-aware traders there's an asymmetric opportunity: buy near $214, target $260 over the next 45 trading days and use a …
Global Ship Lease (GSL) is exposed to a near-term rerating catalyst: a material portion of its fleet rolls off legacy charters into a market with firmer spot/time charter rates. Combine that with recurring trade-route disruptions and tightening vessel supply, and GSL offers an asymmetric upside versus downside if you buy on weakness. This trade pla…
Marvell (MRVL) is squarely in the AI infrastructure story after a $2B strategic investment and an increasingly visible optical and custom-silicon ramp. Fundamentals justify participation, but the stock is expensive and technically overbought. This trade targets a mid-term (~45 trading days) run to $160 with a disciplined stop at $118.
Coeur Mining (CDE) looks mispriced relative to its post-acquisition cash generation profile. The New Gold deal, aggressive $750M repurchase, and new dividend should lift per-share metrics and reduce public float while the company still shows conservative balance sheet metrics. This trade targets a mid-term re-rating toward the January highs, with a…
Bath & Body Works (BBWI) looks cheap on multiple metrics, generates strong free cash flow and pays a healthy yield, but a recent string of missed guidance and active securities litigation create near-term volatility. This trade idea lays out an entry at $18.10 with a stop at $16.50 and a primary target of $24.00 on a 46-180 trading day time frame.
Tyson Foods is reshaping its earnings profile as record beef prices and operational discipline push margins higher. The stock trades with a modest EV/EBITDA of 11.7 and yields ~3%, offering a pragmatic entry for investors willing to give the company a multi-month runway for supply-side recovery and margin normalization.
